Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Modern imaging of pituitary adenomas.

Bashari WA, Senanayake R, Fernández-Pombo A, Gillett D, Koulouri O, Powlson AS, Matys T, Scoffings D, Cheow H, Mendichovszky I, Gurnell M.

Best Pract Res Clin Endocrinol Metab. 2019 May 28. pii: S1521-690X(19)30027-2. doi: 10.1016/j.beem.2019.05.002. [Epub ahead of print] Review.

PMID:
31208872
2.

Multimodal MRI characteristics of the glioblastoma infiltration beyond contrast enhancement.

Yan JL, Li C, Boonzaier NR, Fountain DM, Larkin TJ, Matys T, van der Hoorn A, Price SJ.

Ther Adv Neurol Disord. 2019 May 14;12:1756286419844664. doi: 10.1177/1756286419844664. eCollection 2019.

3.

A rare case of bone marrow infiltration by medulloblastoma in a child.

Santarsieri A, Dickens E, Hook CE, Allinson K, Matys T, Murray MJ.

Br J Haematol. 2019 Jun;185(6):1015. doi: 10.1111/bjh.16041. No abstract available.

PMID:
31172519
4.

Ossification of the pterygoalar and pterygospinous ligaments: a computed tomography analysis of infratemporal fossa anatomical variants relevant to percutaneous trigeminal rhizotomy.

Matys T, Ali T, Zaccagna F, Barone DG, Kirollos RW, Massoud TF.

J Neurosurg. 2019 May 10:1-10. doi: 10.3171/2019.2.JNS182709. [Epub ahead of print]

PMID:
31075780
5.

Characterizing tumor invasiveness of glioblastoma using multiparametric magnetic resonance imaging.

Li C, Wang S, Yan JL, Torheim T, Boonzaier NR, Sinha R, Matys T, Markowetz F, Price SJ.

J Neurosurg. 2019 Apr 26:1-8. doi: 10.3171/2018.12.JNS182926. [Epub ahead of print]

PMID:
31026822
6.

Low perfusion compartments in glioblastoma quantified by advanced magnetic resonance imaging and correlated with patient survival.

Li C, Yan JL, Torheim T, McLean MA, Boonzaier NR, Zou J, Huang Y, Yuan J, van Dijken BRJ, Matys T, Markowetz F, Price SJ.

Radiother Oncol. 2019 May;134:17-24. doi: 10.1016/j.radonc.2019.01.008. Epub 2019 Jan 31.

7.

Non-invasive assessment of glioma microstructure using VERDICT MRI: correlation with histology.

Zaccagna F, Riemer F, Priest AN, McLean MA, Allinson K, Grist JT, Dragos C, Matys T, Gillard JH, Watts C, Price SJ, Graves MJ, Gallagher FA.

Eur Radiol. 2019 Mar 19. doi: 10.1007/s00330-019-6011-8. [Epub ahead of print]

PMID:
30888488
8.

A Phase I Study of Pegylated Arginine Deiminase (Pegargiminase), Cisplatin, and Pemetrexed in Argininosuccinate Synthetase 1-Deficient Recurrent High-grade Glioma.

Hall PE, Lewis R, Syed N, Shaffer R, Evanson J, Ellis S, Williams M, Feng X, Johnston A, Thomson JA, Harris FP, Jena R, Matys T, Jefferies S, Smith K, Wu BW, Bomalaski JS, Crook T, O'Neill K, Paraskevopoulos D, Khadeir RS, Sheaff M, Pacey S, Plowman PN, Szlosarek PW.

Clin Cancer Res. 2019 May 1;25(9):2708-2716. doi: 10.1158/1078-0432.CCR-18-3729. Epub 2019 Feb 22.

PMID:
30796035
9.

Multi-parametric and multi-regional histogram analysis of MRI: modality integration reveals imaging phenotypes of glioblastoma.

Li C, Wang S, Serra A, Torheim T, Yan JL, Boonzaier NR, Huang Y, Matys T, McLean MA, Markowetz F, Price SJ.

Eur Radiol. 2019 Feb 1. doi: 10.1007/s00330-018-5984-z. [Epub ahead of print]

PMID:
30707277
10.

Quantifying normal human brain metabolism using hyperpolarized [1-13C]pyruvate and magnetic resonance imaging.

Grist JT, McLean MA, Riemer F, Schulte RF, Deen SS, Zaccagna F, Woitek R, Daniels CJ, Kaggie JD, Matys T, Patterson I, Slough R, Gill AB, Chhabra A, Eichenberger R, Laurent MC, Comment A, Gillard JH, Coles AJ, Tyler DJ, Wilkinson I, Basu B, Lomas DJ, Graves MJ, Brindle KM, Gallagher FA.

Neuroimage. 2019 Apr 1;189:171-179. doi: 10.1016/j.neuroimage.2019.01.027. Epub 2019 Jan 11.

11.

Corrigendum to "Routine preoperative brain CT in resectable non-small cell lung cancer-Ten years experience from a tertiary UK thoracic center" [Lung Cancer 122 (August) (2018) 195-199].

Matys T, Drury R, David S, Rassl DM, Qian W, Rintoul RC, Screaton NJ.

Lung Cancer. 2018 Nov;125:300. doi: 10.1016/j.lungcan.2018.09.016. Epub 2018 Oct 1. No abstract available.

PMID:
30287081
12.

Intratumoral Heterogeneity of Glioblastoma Infiltration Revealed by Joint Histogram Analysis of Diffusion Tensor Imaging.

Li C, Wang S, Yan JL, Piper RJ, Liu H, Torheim T, Kim H, Zou J, Boonzaier NR, Sinha R, Matys T, Markowetz F, Price SJ.

Neurosurgery. 2018 Sep 17. doi: 10.1093/neuros/nyy388. [Epub ahead of print]

PMID:
30239840
13.

Routine preoperative brain CT in resectable non-small cell lung cancer - Ten years experience from a tertiary UK thoracic center.

Matys T, Drury R, David S, Rassl DM, Qian W, Rintoul RC, Screaton NJ.

Lung Cancer. 2018 Aug;122:195-199. doi: 10.1016/j.lungcan.2018.06.014. Epub 2018 Jun 10. Erratum in: Lung Cancer. 2018 Nov;125:300.

PMID:
30032831
14.

Imaging practice in low-grade gliomas among European specialized centers and proposal for a minimum core of imaging.

Freyschlag CF, Krieg SM, Kerschbaumer J, Pinggera D, Forster MT, Cordier D, Rossi M, Miceli G, Roux A, Reyes A, Sarubbo S, Smits A, Sierpowska J, Robe PA, Rutten GJ, Santarius T, Matys T, Zanello M, Almairac F, Mondot L, Jakola AS, Zetterling M, Rofes A, von Campe G, Guillevin R, Bagatto D, Lubrano V, Rapp M, Goodden J, De Witt Hamer PC, Pallud J, Bello L, Thomé C, Duffau H, Mandonnet E.

J Neurooncol. 2018 Sep;139(3):699-711. doi: 10.1007/s11060-018-2916-3. Epub 2018 Jul 10.

15.

Imaging intralesional heterogeneity of sodium concentration in multiple sclerosis: Initial evidence from 23Na-MRI.

Grist JT, Riemer F, McLean MA, Matys T, Zaccagna F, Hilborne SF, Mason JP, Patterson I, Slough R, Kaggie J, Deen SS, Graves MJ, Jones JL, Coles AJ, Gallagher FA.

J Neurol Sci. 2018 Apr 15;387:111-114. doi: 10.1016/j.jns.2018.01.027. Epub 2018 Feb 6.

16.

Local alkylating chemotherapy applied immediately after 5-ALA guided resection of glioblastoma does not provide additional benefit.

Sage W, Guilfoyle M, Luney C, Young A, Sinha R, Sgubin D, McAbee JH, Ma R, Jefferies S, Jena R, Harris F, Allinson K, Matys T, Qian W, Santarius T, Price S, Watts C.

J Neurooncol. 2018 Jan;136(2):273-280. doi: 10.1007/s11060-017-2649-8. Epub 2017 Nov 14.

17.

Correlation of volumetric growth and histological grade in 50 meningiomas.

Soon WC, Fountain DM, Koczyk K, Abdulla M, Giri S, Allinson K, Matys T, Guilfoyle MR, Kirollos RW, Santarius T.

Acta Neurochir (Wien). 2017 Nov;159(11):2169-2177. doi: 10.1007/s00701-017-3277-y. Epub 2017 Aug 9.

PMID:
28791500
18.

Multiparametric MR Imaging of Diffusion and Perfusion in Contrast-enhancing and Nonenhancing Components in Patients with Glioblastoma.

Boonzaier NR, Larkin TJ, Matys T, van der Hoorn A, Yan JL, Price SJ.

Radiology. 2017 Jul;284(1):180-190. doi: 10.1148/radiol.2017160150. Epub 2017 Feb 27.

PMID:
28240563
19.

Volumetric growth rates of meningioma and its correlation with histological diagnosis and clinical outcome: a systematic review.

Fountain DM, Soon WC, Matys T, Guilfoyle MR, Kirollos R, Santarius T.

Acta Neurochir (Wien). 2017 Mar;159(3):435-445. doi: 10.1007/s00701-016-3071-2. Epub 2017 Jan 18. Review.

20.

Posttreatment Apparent Diffusion Coefficient Changes in the Periresectional Area in Patients with Glioblastoma.

van der Hoorn A, Yan JL, Larkin TJ, Boonzaier NR, Matys T, Price SJ.

World Neurosurg. 2016 Aug;92:159-165. doi: 10.1016/j.wneu.2016.04.129. Epub 2016 May 9.

PMID:
27185650
21.

Validation of a semi-automatic co-registration of MRI scans in patients with brain tumors during treatment follow-up.

van der Hoorn A, Yan JL, Larkin TJ, Boonzaier NR, Matys T, Price SJ.

NMR Biomed. 2016 Jul;29(7):882-9. doi: 10.1002/nbm.3538. Epub 2016 Apr 27.

PMID:
27120035
22.

Extent of resection of peritumoral diffusion tensor imaging-detected abnormality as a predictor of survival in adult glioblastoma patients.

Yan JL, van der Hoorn A, Larkin TJ, Boonzaier NR, Matys T, Price SJ.

J Neurosurg. 2017 Jan;126(1):234-241. doi: 10.3171/2016.1.JNS152153. Epub 2016 Apr 8.

PMID:
27058207
23.

Is CT-Based Perfusion and Collateral Imaging Sensitive to Time Since Stroke Onset?

Agarwal S, Matys T, Marrapu ST, Scoffings DJ, Mitchell J, Jones PS, Baron JC, Warburton EA.

Front Neurol. 2015 Apr 9;6:70. doi: 10.3389/fneur.2015.00070. eCollection 2015.

24.

The aqueduct of Sylvius: applied 3-T magnetic resonance imaging anatomy and morphometry with neuroendoscopic relevance.

Matys T, Horsburgh A, Kirollos RW, Massoud TF.

Neurosurgery. 2013 Dec;73(2 Suppl Operative):ons132-40; discussion ons140. doi: 10.1227/01.neu.0000430286.08552.ca.

PMID:
23615083
25.

Tuber cinereum proximity to critical major arteries: a morphometric imaging analysis relevant to endoscopic third ventriculostomy.

Horsburgh A, Matys T, Kirollos RW, Massoud TF.

Acta Neurochir (Wien). 2013 May;155(5):891-900. doi: 10.1007/s00701-013-1661-9. Epub 2013 Mar 7.

PMID:
23468037
26.

Tissue plasminogen activator in the bed nucleus of stria terminalis regulates acoustic startle.

Matys T, Pawlak R, Strickland S.

Neuroscience. 2005;135(3):715-22. Epub 2005 Aug 26.

PMID:
16125860
27.

Ethanol-withdrawal seizures are controlled by tissue plasminogen activator via modulation of NR2B-containing NMDA receptors.

Pawlak R, Melchor JP, Matys T, Skrzypiec AE, Strickland S.

Proc Natl Acad Sci U S A. 2005 Jan 11;102(2):443-8. Epub 2005 Jan 3.

28.

Tissue plasminogen activator promotes the effects of corticotropin-releasing factor on the amygdala and anxiety-like behavior.

Matys T, Pawlak R, Matys E, Pavlides C, McEwen BS, Strickland S.

Proc Natl Acad Sci U S A. 2004 Nov 16;101(46):16345-50. Epub 2004 Nov 2.

29.

Nitric oxide-dependent antiplatelet action of AT1-receptor antagonists in a pulmonary thromboembolism in mice.

Matys T, Kucharewicz I, Pawlak R, Chabielska E, Domaniewski T, Buczko W.

J Cardiovasc Pharmacol. 2003 Dec;42(6):710-3.

PMID:
14639091
30.

Peripheral distribution of kynurenine metabolites and activity of kynurenine pathway enzymes in renal failure.

Pawlak D, Tankiewicz A, Matys T, Buczko W.

J Physiol Pharmacol. 2003 Jun;54(2):175-89.

31.

Tissue plasminogen activator and NMDA receptor cleavage.

Matys T, Strickland S.

Nat Med. 2003 Apr;9(4):371-2; author reply 372-3. No abstract available. Erratum in: Nat Med. 2003 Jul;9(7):975.

PMID:
12669038
32.

Angiotensin-(1-7): an active member of the renin-angiotensin system.

Kucharewicz I, Pawlak R, Matys T, Chabielska E, Buczko W.

J Physiol Pharmacol. 2002 Dec;53(4 Pt 1):533-40. Review.

33.

Antithrombotic effect of captopril and losartan is mediated by angiotensin-(1-7).

Kucharewicz I, Pawlak R, Matys T, Pawlak D, Buczko W.

Hypertension. 2002 Nov;40(5):774-9.

PMID:
12411476
34.

Angiotensin II AT1 receptor antagonists inhibit platelet adhesion and aggregation by nitric oxide release.

Kalinowski L, Matys T, Chabielska E, Buczko W, Malinski T.

Hypertension. 2002 Oct;40(4):521-7.

PMID:
12364357
35.

Propranolol modifies platelet serotonergic mechanisms in rats.

Zółtowski R, Pawlak R, Matys T, Pietraszek M, Buczko W.

J Physiol Pharmacol. 2002 Jun;53(2):265-74.

36.

The antithrombotic effect of angiotensin-(1-7) closely resembles that of losartan.

Kucharewicz I, Chabielska E, Pawlak D, Matys T, Rólkowski R, Buczko W.

J Renin Angiotensin Aldosterone Syst. 2000 Sep;1(3):268-72.

PMID:
11881036
37.

The involvement of AT(2)-receptor in the antithrombotic effect of losartan in renal hypertensive rats.

Chabielska E, Matys T, Kucharewicz I, Pawlak D, Rólkowski R, Buczko W.

J Renin Angiotensin Aldosterone Syst. 2000 Sep;1(3):263-7.

PMID:
11881035
38.

Possible involvement of kynurenamines in the pathogenesis of cataract in diabetic patients.

Andrzejewska-Buczko J, Pawlak D, Tankiewicz A, Matys T, Buczko W.

Med Sci Monit. 2001 Jul-Aug;7(4):742-5.

PMID:
11433204
39.

Studies on the antithrombotic action of AT1 receptor antagonists.

Buczko W, Matys T, Pawlak R, Kucharewicz I, Chabielska E.

Med Sci Monit. 2001 Jul-Aug;7(4):600-5.

PMID:
11433183
40.

Losartan inhibits the adhesion of rat platelets to fibrillar collagen--a potential role of nitric oxide and prostanoids.

Matys T, Chabielska E, Pawlak R, Kucharewicz I, Buczko W.

J Physiol Pharmacol. 2000 Dec;51(4 Pt 1):705-13.

41.

The role of the thiol group in the antithrombotic action of captopril.

Pawlak R, Chabielska E, Matys T, Kucharewicz I, Buczko W.

Thromb Haemost. 2000 Nov;84(5):919-20. No abstract available.

PMID:
11127878
42.

Thiol repletion prevents venous thrombosis in rats by nitric oxide/prostacyclin-dependent mechanism: relation to the antithrombotic action of captopril.

Pawlak R, Chabielska E, Matys T, Kucharewicz I, Rółkowski R, Buczko W.

J Cardiovasc Pharmacol. 2000 Oct;36(4):503-9.

PMID:
11026653
43.

Hypotensive effect of angiotensin II after AT1-receptor blockade with losartan.

Matys T, Pawlak R, Kucharewicz I, Chabielska E, Buczko W.

J Physiol Pharmacol. 2000 Mar;51(1):161-6.

44.

The role of endothelium in antithrombotic effect of the renin-angiotensin system blockade.

Buczko W, Matys T, Kucharewicz I, Chabielska E.

J Physiol Pharmacol. 1999 Dec;50(4):499-507. Review.

PMID:
10639001
45.

[Secretory activity of the stomach in chronic renal failure. Secretion of pepsin, sodium, potassium and chlorine].

Szepietowski T, Kuźniar J, Matys T.

Pol Tyg Lek. 1973 Jun 4;28(23):849-52. Polish. No abstract available.

PMID:
4578438
46.

[Hydrochloric acid and urea secretion in chronic renal failure].

Szepietowski T, Kuźniar J, Matys T.

Pol Tyg Lek. 1973 Feb 5;28(6):197-200. Polish. No abstract available.

PMID:
4691183

Supplemental Content

Support Center